» Articles » PMID: 21976463

HIV Infection, Immune Suppression, and Uncontrolled Viremia Are Associated with Increased Multimorbidity Among Aging Injection Drug Users

Overview
Journal Clin Infect Dis
Date 2011 Oct 7
PMID 21976463
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Despite an increasing burden of age-associated non-AIDS outcomes, few studies have investigated the prevalence or correlates of multimorbidity among aging human immunodeficiency virus (HIV)-infected and epidemiologically comparable at-risk populations.

Methods: Among 1262 AIDS Linked to the IntraVenous Experience (ALIVE) study participants followed in a community-based observational cohort, we defined the prevalence of 7 non-AIDS-defining chronic conditions (diabetes, obstructive lung disease, liver disease, anemia, obesity, kidney dysfunction, and hypertension) using clinical and laboratory criteria. Ordinal logistic regression was used to model the odds of increased multimorbidity associated with demographic, behavioral, and clinical factors. Self-reported prevalence was compared with clinically defined prevalence.

Results: Participants were a median of 48.9 years of age; 65.1% were male, 87.5% were African-American, and 28.7% were HIV infected. In multivariable analysis, HIV infection (odds ratio [OR], 1.50; 95% confidence interval [CI], 1.13-1.99) was positively associated with increased multimorbidity. Among HIV-infected participants, multimorbidity was increased with lower nadir CD4 T-cell count (OR, 1.14 per 100-cell decrease; 95% CI, 1.00-1.29) and higher current HIV RNA (OR, 1.32 per log(10) increase; 95% CI, 1.08-1.60). Older age, being female, not using cigarettes or drugs, and having depressive symptoms were also associated with increased multimorbidity. A substantial proportion of multimorbid conditions in HIV-infected and HIV-uninfected participants were unrecognized and untreated.

Conclusions: HIV-infected participants experienced increased numbers of multimorbid conditions; risk increased with advanced immunosuppression and higher viremia. These results underscore the heavy burden of multimorbidity associated with HIV and highlight the need for incorporating routine assessment and integrated management of chronic diseases as part of comprehensive healthcare for aging, HIV-infected persons.

Citing Articles

The interaction between central and peripheral immune systems in methamphetamine use disorder: current status and future directions.

Shi S, Sun Y, Zan G, Zhao M J Neuroinflammation. 2025; 22(1):40.

PMID: 39955589 PMC: 11829452. DOI: 10.1186/s12974-025-03372-z.


Association of inadequate sleep with mortality among persons who inject drugs.

Sun J, Hsu H, Rabinowitz J, Sosnowski D, Piggott D, Mehta S Sleep Health. 2024; 10(6):651-657.

PMID: 39278806 PMC: 11624996. DOI: 10.1016/j.sleh.2024.07.008.


Evaluation of viral suppression and medication-related burden among HIV-infected adults in a secondary care facility.

Hedima E, Ohieku J, David E, Ikunaiye N, Nasir A, Alfa M Explor Res Clin Soc Pharm. 2024; 15:100473.

PMID: 39108330 PMC: 11301334. DOI: 10.1016/j.rcsop.2024.100473.


Baltimore oral epidemiology, disease effects, and HIV evaluation study (BEEHIVE) study protocol: a prospective cohort study.

Weatherspoon D, Kirk G, Piggott D, Thumbigere-Math V, Dye B, Macek M BMC Oral Health. 2024; 24(1):439.

PMID: 38600460 PMC: 11008028. DOI: 10.1186/s12903-024-04200-1.


Characterizing multimorbidity in ALIVE: comparing single and ensemble clustering methods.

Rudolph J, Lau B, Genberg B, Sun J, Kirk G, Mehta S Am J Epidemiol. 2024; 193(8):1146-1154.

PMID: 38576181 PMC: 11299029. DOI: 10.1093/aje/kwae031.


References
1.
Kitahata M . When to start antiretroviral therapy. Top HIV Med. 2010; 18(3):121-6. View

2.
Gijsen R, Hoeymans N, Schellevis F, Ruwaard D, Satariano W, van den Bos G . Causes and consequences of comorbidity: a review. J Clin Epidemiol. 2001; 54(7):661-74. DOI: 10.1016/s0895-4356(00)00363-2. View

3.
Yancik R, Ershler W, Satariano W, Hazzard W, Cohen H, Ferrucci L . Report of the national institute on aging task force on comorbidity. J Gerontol A Biol Sci Med Sci. 2007; 62(3):275-80. PMC: 2645628. DOI: 10.1093/gerona/62.3.275. View

4.
Effros R, Fletcher C, Gebo K, Halter J, Hazzard W, Horne F . Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis. 2008; 47(4):542-53. PMC: 3130308. DOI: 10.1086/590150. View

5.
Swendeman D, Ingram B, Rotheram-Borus M . Common elements in self-management of HIV and other chronic illnesses: an integrative framework. AIDS Care. 2009; 21(10):1321-34. PMC: 2881847. DOI: 10.1080/09540120902803158. View